Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03781492

Stable Angina Management and Treatment

Prospective REgistry of Stable Angina manaGEment and Treatment

Status
Recruiting
Phase
Study type
Observational
Enrollment
25,000 (estimated)
Sponsor
Silesian Centre for Heart Diseases · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is an observational study on an all-comer stable angina population hospitalised in a highly specialized cardiovascular centre with cardiac surgery facilities. The aim of the study is to assess the clinical characteristics, treatment modalities, early and long-term outcomes in this population.

Detailed description

The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is a single-center, observational study recruiting consecutive patients with stable angina, who were diagnosed and treated in the 3rd Chair and Department of Cardiology in the Silesian Centre for Heart Diseases in Zabrze, Poland. The Silesian Centre for Heart Diseases is a highly specialised cardiology centre with cardiac surgery facilities The main objective of the PRESAGE Registry is to clarify the overall clinical characteristics of patients with stable angina, their demographics and clinical profile, current management, early and long-term outcomes, with regard to the administered treatment. The diagnosis of stable angina was based on clinical characterization, coronary angiography, and the current guidelines of the European Society of Cardiology. Patients with vasospastic and/or microvascular angina were also included to the registry. Performance of coronary angiography is the criterion of the enrolment in the registry. Patients with acute coronary syndromes are excluded from the analysis. Data collection is patient-based (not event-based). Complete patient demographics: medical history, complete hospitalization data (diagnostic and therapeutic) and in-hospital results are collected in an electronic form by the attending physician. The patients are under constant follow-up for all-cause mortality and major cardiac adverse events.

Conditions

Timeline

Start date
2006-01-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2018-12-20
Last updated
2020-05-26

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT03781492. Inclusion in this directory is not an endorsement.